“A brilliant team who collaborate to deliver innovative discovery cancer science and patient benefit.” This is the refreshed sense of purpose that the Cancer Sciences Unit is bringing to life right now. This is the “Why”. The order of words
Last week I was in Norway attending the annual meeting of the RHINESSA study. It is always a pleasure to visit the lovely city of Bergen and catch up with colleagues who have now become friends. This week I am
Last week, Faculty of Medicine staff received an email highlighting local changes to the policy on scientific publishing that are driven by the move to fully compliant open access. Amongst other things, this email mentioned Plan S and provided a
As Brexit becomes even more unclear, we cancer immunologists have been looking outward with a view to building stronger links with centres of excellence worldwide. I had the privilege of taking a representative delegation of cancer immunologists from across the faculty to
Early December, and National Osteoporosis Society Annual Osteoporosis Conference, saw a busy few days for UK bone clinicians and researchers, not least those of us involved in organising, and contribution to, the meeting.
The advocates of big data sometimes claim that, given enough data, tedious epidemiological concerns about data that is not missing at random, other causes of bias or confounding will become irrelevant, so that randomised trials will become unnecessary.
The doors to the Centre for Cancer Immunology have been open for just over a month now, with everyone settling in to their new routines and ways of going about their day, and I can’t help feeling an immense sense